LumiHeal® Treatment
 

A wound care solution for better outcomes

The LumiHeal System utilizes the principles of Fluorescence Biomodulation to manage impaired and damaged skin by delivering fluorescence, at a cellular level, to impact the three (3) critical phases of healing: Inflammation, Proliferation and Remodeling. This active wound care solution delivers high response rates and ignites the onset of wound regression, while providing an excellent safety profile. LumiHeal offers an innovative, pain free, non-invasive, cost-effective alternative to manage chronic and acute wounds. Despite the many different traditional treatment options available, many patients don’t respond and are subjected to significant discomfort and distress while draining the medical system of global healthcare resources.

 

The Cutting Edge of Wound Care

LumiHeal is supported by strong scientific evidence, multiple clinical studies and a CE mark in Europe for a variety of wound types including chronic wounds. LumiHeal’s unique mode of action in which fluorescence is the essential part brings much needed innovation to the wound care space, especially given the ballooning costs of stalled and non-responding wounds. Clinicians are seeking solutions that would allow them to optimally treat hard-to-heal patients reducing the burden on global healthcare systems.

 

Restoring Patient Lives with LumiHeal

Upon LED activation, the Light Absorbing Molecule (LAM) topical generates fluorescence, which penetrates the skin at various depths to deliver high response rates and ignite the fast onset of wound regression, while providing an excellent safety profile. Patients and clinicians report efficacy, ease of use and high levels of satisfaction over current standards of care.

 

“Lumiheal has the potential to become an alternative for unmet needs in the management of chronic ulcers”
Eureka Clinical Investigator

Our Treatment

Satisfaction

95% of investigators would recommend LumiHeal™ to a colleague, rating it high in effectiveness, safety and ease of use

Response rate

82% of patients responded positively and could be classified as a responder by week three (3), allowing for anticipatory discontinuation of non-responders

Wound regression

A 50% reduction of in wound surface area was observed after only four (4) weeks of treatment and an 80% reduction was observed after ten (10) weeks

Low infection rate

Only 3% of wounds developed an infection during the study period, demonstrating the antibacterial properties of LumiHeal

Safety

There were no serious adverse events and three (3) mild adverse events reported during the entirety of the study period

After One (1) Month of LumiHeal

BEFORE: 26 cm2

AFTER: 0 cm2

After Three (3) Months of LumiHeal

BEFORE: 23 cm2

AFTER: 0 cm2

LumiHeal. Simple and Effective.

LumiHeal is a quick and simple procedure enabling both doctors and nurses to treat patients in the hospital, the clinic and the home setting.A thin layer of LAM gel is applied to affected skin after wound debridement and/or cleaning
The LAM topical is illuminated by the LED Activator for 5 minutes per application (topical is not internalized or metabolized)
Following illumination, the LAM topical is removed and the skin is cleansed
Read about “Photobiomodulation with LumiHeal Made Easy” published in Wounds International

 

LumiHeal. Anywhere.

With advancements in portable electronics, the LED Activator is transitioning from a hospital device to a portable, handheld version to address the growing homecare market, affordability and ease of use.

The portable LED Activator is an extremely low costing unit that allows us to reach a wider range of patient in all care settings.

 

Hospital/Clinic LED Activator

Simple logistics and supply

Permits versatile coverage for large surface areas

Available for hospital and clinic use

Portable LED Activator

Light-weight and battery operated

Compact and easy to transport

Simple logistics and supply

Permits versatile coverage for various surface areas

Available for hospital, clinic and home-care use

Customized LumiHeal Benefits in the Three Critical Phases of Wound Healing

Our solutions start with a need. Current wound care technologies aren’t required to address the different phases of healing and typically focus on one phase per product. We want to impact all three phases of wound healing to bring wounds to a close in a way that makes doctors and patients happy with the overall outcome. Wound healing is a complex, highly regulated process involving three (3) main phases of healing that are critical in maintaining the function of skin: Inflammation, Proliferation and Remodeling.

 

LumiHeal delivers fluorescence to various layers of the skin, uniquely benefiting all three (3) phases of healing

Inflammation

Dilation of blood vessels occurs, which allows cells to migrate to the affected area(s), specifically white blood cells, antibodies, growth factors, enzymes and nutrients. Signs of oedema, erythema, heat and/or pain can be seen.

Proliferation

Granulation tissue develops following the induction of growth factors and collagen as well as the stimulation of angiogenesis (creation of new blood vessels).

Tissue Remodeling

Sometimes known as the Maturation phase, there is remodeling of collagen along with a reduction of blood vessel development. This phase can last a year or longer.

LumiHeal chart correction

Promotes an environment that controls bacterial growth

Anti-inflammatory modulation

Induction of cell proliferation

Increase in collagen production

Stimulation of angiogenesis

Re-epithelization

Reorganization of collagen

Scar maturation

What are Chronic Wounds?

Chronic wounds become arrested during the healing process due to a variety of factors. This leads to various complications such as progressive laceration of skin, necrosis of surrounding tissue, and impaired healing ability. Chronic and other hard to heal wounds affect approximately 20 million patients around the world annually, according to research published in Advances in Skin & Wound Care. The annual cost to the United States healthcare system of chronic wound treatment and related complications was estimated to exceed $25 billion in 2010, according to research published in Wound Repair and Regeneration. The number of patients affected is growing yearly, given the increasing prevalence of diabetes and obesity as well as the aging population, which all affect wound healing.

 

Want to be contacted?

If you want to be contacted by the FB Dermatology® sales team fill out the form below and our local sales representative will contact you shortly

 
 
 
 
 
 
 
I agree to the Privacy policy and I consent to the processing and storage of my personal data*.
 
I agree to be contacted for marketing and commercial purposes*